Keyu Li

Title: Keyu Li - Innovator in Human Antibody Research

Introduction

Keyu Li is a prominent inventor based in Sunnyvale, CA, who has made significant contributions to the field of biotechnology. His work focuses on the development of fully human antibodies that have the potential to revolutionize cancer treatment and diagnostics.

Latest Patents

Keyu Li holds a patent for "Fully human antibodies and fragments recognizing human c-Met." This innovative patent describes human antibody fragments against c-Met that have been identified through phage display technology. The high affinity and low immunogenicity of these antibodies make them particularly useful for both in vivo and in vitro applications. These novel human antibodies can greatly assist in studying drug resistance in EGFR-targeted therapies, thereby improving the diagnosis and treatment of cancer patients. He has 1 patent to his name.

Career Highlights

Keyu Li is affiliated with the University of California, where he conducts his research and development work. His expertise in antibody technology has positioned him as a key figure in the ongoing fight against cancer.

Collaborations

Keyu collaborates with Anna M Wu, who is also involved in research related to human antibodies. Their combined efforts aim to enhance the understanding and treatment of various cancers.

Conclusion

Keyu Li's innovative work in the field of human antibodies represents a significant advancement in cancer research. His contributions have the potential to improve patient outcomes and pave the way for future breakthroughs in medical science.